New Zealand markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9400+0.0700 (+3.75%)
As of 03:34PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
82,248
124,775
208,892
304,962
Other short-term investments
0
42,086
50,441
0
Total cash
82,248
166,861
259,333
304,962
Net receivables
48,494
33,729
22,934
12,388
Inventory
65,623
35,201
34,394
16,136
Other current assets
4,507
9,866
11,173
-
Total current assets
201,065
246,683
328,972
345,896
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,687
3,751
4,613
8,877
Accumulated depreciation
-2,012
-2,551
-2,051
-1,571
Net property, plant and equipment
4,675
1,200
2,562
7,306
Intangible assets
-
-
-
56
Other long-term assets
-
-
50,000
-
Total non-current assets
4,731
1,256
52,618
7,362
Total assets
205,796
247,939
381,590
353,258
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
31,718
23,040
17,559
51,975
Accrued liabilities
86,782
56,324
39,909
22,684
Deferred revenues
25,402
3,507
5,683
1,662
Total current liabilities
156,224
92,308
73,352
94,069
Non-current liabilities
Long-term debt
261,596
259,899
258,280
179,367
Deferred revenues
-
0
634
0
Other long-term liabilities
239,950
218,845
245,744
172,502
Total non-current liabilities
504,566
479,409
505,182
355,323
Total liabilities
660,790
571,717
578,534
449,392
Stockholders' equity
Common stock
118
75
61
26
Retained earnings
-1,549,284
-1,340,036
-1,106,377
-838,817
Accumulated other comprehensive income
0
-2
-31
0
Total stockholders' equity
-454,994
-323,778
-196,944
-96,134
Total liabilities and stockholders' equity
205,796
247,939
381,590
353,258